The Munich Eye: Lowering Bad Cholesterol Linked to Reduced Alzheimer’s Risk
June 2, 2025
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More
June 2, 2025
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More
June 2, 2025
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
June 2, 2025
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
June 2, 2025
Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article in which Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was also mentioned. Read More
June 2, 2025
Research by The University of Texas Health Science Center at San Antonio was featured in this article. Read More
May 30, 2025
Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More